Improving the In Vivo Therapeutic Index of siRNA Polymer Conjugates through Increasing pH Responsiveness
Erin N. Guidry(Merck & Co., Inc., Rahway, NJ, USA (United States)), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Kathleen Calati(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nancy J. Kevin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Craig A. Parish(Merck & Co., Inc., Rahway, NJ, USA (United States)), Julie Farand(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ian W. Davies(Princeton University), Bonnie J. Howell(Johns Hopkins University), R. M. Garbaccio(United States Military Academy), Arash Soheili(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rubina Parmar(Alnylam Pharmaceuticals (United States)), Stephanie E. Barrett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jacob H. Waldman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew H. Latham(United States Military Academy), Brenda Pipik(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bing Mao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Quang Tri Truong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), N. Ikemoto(Star Technology and Research (United States)), Anthony Leone
Cited by 19
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
The importance of synthetic chemistry in the pharmaceutical industry
|Science|2019|650
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409